pharmaceutical care untuk pasien penyakit arthritis ... - Binfar Depkes

17. Hawkins D.W., Rahn D.W., Gout and Hyperuricemia, Pharmacotherapy , Apathophysiological Approach, McGraw-Hill 200518. Bandolier team, Epidemiology of gout, Bandolier, 200519. Bandolier team, Prevalence and Incidence of Gout, Bandolier, 200220. Bandolier team, An introduction to Gout, Bandolier21. Wood J. , Gout and its Management, The Pharmaceutical Journal vol 262June 5, 199922. Jordan K.M., An Update on Gout, Topical Reviews, Arthritis ResearchCampaign, October 200423. Pittman J.R., Bross M.B., Diagnosis and Management of Gout, AmericanFamily Physician , The American Academy of Family Physicians , April199924. NIAMS, Questions and Answers About Gout, Health Topics, NationalInstitute of Health, March 2002.25. Schlesinger N., Diagnosis of Gout, Laboratory, and Radiology Findings,The American Journal of MANAGED CARE, Nov 200526. Wallace SL et al, Preliminary criteria for the classification of the acutearthritis of primary gout., American College of Rheumatology, 197727. Johnstone, A., The disease and non-drug treatment, Hospital Pharmacist, vol12, November 200528. McCarty, D.J. Gout, Hyperuricemia, and Crystal-Associated Arthropathies,Best Practice of Medicine, December 2003.29. Morehead K., Sack K.E, What therapies for this disease of many causes?Postgraduate Medicine, Vol 114/no 5/ November 200330. Thompson W.G., NSAID: Good for the Joints, Bad for the Gut?International Foundation for Functional Gastrointestinal Disorders, Inc(IFFGD) , August 29, 2005